We are delighted to introduce our inaugural Advisory Board for RSC Pharmaceutics! Our Advisory Board is comprised of internationally renowned researchers working within the field of pharmaceutics.
Please join us in welcoming our new Advisory Board members:
- Andrew Lewis, Quotient Sciences, UK
- Audra Stinchcomb, School of Pharmacy, University of Maryland, USA
- Avi Schroeder, Technion, Israel Institute of Technology, Isreal
- Dimitrios Lamprou, Queens University Belfast, Northern Ireland
- Eliana Lima, Universidade Federal de Goias, Brazil
- Faisal Raza, Shanghai Jiao Tong University, China
- Lingling Shen, Novartis, USA
- Priyabrata Mukherjee, University of Oklahoma Health Sciences Centre, USA
- Raju Vivek, Bharathiar University, India
- Scott Mitchell, Aragón Nanoscience and Materials Institute (INMA), Spain
- Anthony Hickey, University of North Carolina at Chapel Hill, USA
- Twan Lammers, RWTH Aachen University Clinic, Germany
- Naved Malek, Sardar Vallabhbhai National Institute of Technology, India
- Wilson Poon, University of Texas at El Paso, USA
- Emily Day, University of Delaware, USA
- Hitesh Kulhari, Central University of Gujarat, India
- Yahya Choonara, University of the Witwatersrand, South Africa
- Sara Cordeiro, Leicester School of Pharmacy, De Montfort University, UK
We are excited to welcome our new Advisory Board members to our journal community and look forward to working with them as we shape and grow the journal.
RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is open for submissions.
Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.
Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.